Skip to content
DefDex

Federal award

DIAGNOSTIC HYBRIDS INC

W91YTV13C0010

Contract

Obligated and Ceiling

Obligated (net)
$244,827.82
Ceiling (potential value, not spending)
$244,827.82
Current value
$244,827.82
Gross positive obligations
$353,369.24

Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.

Award Details

Recipient
DIAGNOSTIC HYBRIDS INC · SWUKAJ3C95L1
Owner company
Not a reviewed companyNo reviewed company owns this recipient.
Reported parent
QUIDEL CORP · VNAKZRHYAUC7
Awarding agency
Department of War · sub-agency 2100 · office W81K04
Funding agency
Department of War · sub-agency 2100
Product or service (PSC)
6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
Industry (NAICS)
325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
PIID
W91YTV13C0010
Award type code
D
Actions
18 · May 9, 2013 to Apr 13, 2022
Why it is listed
gross positive obligations of $100k or more (contracts)

Open this award on USAspending →

Action History18

Award actions
DateFYModAction typeObligationCompany in company totals
Apr 13, 2022FY2022P00017F−$28,171.50
—
Jan 25, 2021FY2021P00016F−$12,927.90
—
Jun 11, 2020FY2020P00015F−$14,705.86
—
Feb 22, 2019FY2019P00014F−$4,112.43
—
May 7, 2018FY2018P00013C−$17,547.08
—
May 30, 2017FY2017P00012C$15,450.00
—
Dec 13, 2016FY2017P00011C$69,327.96
—
Jul 27, 2016FY2016P00010G−$0.01
—
Nov 4, 2015FY2016P00009C$66,558.96
—
Oct 6, 2015FY2016P00008M$0.00
—
Sep 21, 2015FY2015P00007G$0.00
—
Mar 11, 2015FY2015P00006B$14,850.00
—
Oct 22, 2014FY2015P00005C$66,038.96
—
Aug 21, 2014FY2014P00004G$0.00
—
Jan 7, 2014FY2014P00003C$63,868.48
—
Sep 5, 2013FY2013P00002G$0.00
—
Jul 24, 2013FY2013P00001B−$31,076.64
—
May 9, 2013FY20130—$57,274.88
—

Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.